In case you missed it, last week, Veranova’s Solid Form Scientists, Shane Cullen, and Jethro Beamish-Cook delivered a Scientific Update Ltd webinar discussing the role of crystallization control and particle engineering in obtaining solid form APIs with optimal physiochemical properties. During the webinar, Shane and Jethro shared a real-life case study with insights into each stage of the development process, from initial form discovery and screening to scale-up and implementation of particle engineering controls. To learn more, sign up to watch the full webinar on-demand: https://lnkd.in/guT2gu4J
关于我们
Veranova is a global leader in process development and manufacturing of active pharmaceutical ingredients (APIs), focused on specialty niches with expertise in highly regulated and complex chemistries. Veranova is headquartered in Wayne, PA and has operations in North America and Europe. For more information, please visit www.veranova.com
- 网站
-
https://www.veranova.com
Veranova的外部链接
- 所属行业
- 制药业
- 规模
- 501-1,000 人
- 总部
- Wayne,Pennsylvania
- 类型
- 私人持股
- 创立
- 2022
地点
-
主要
435 Devon Park Dr
Suite 400
US,Pennsylvania,Wayne,19087
Veranova员工
动态
-
Veranova is proud to announce that Cécile Maupas, Senior Vice President and Chief Commercial Officer, is now directly responisble for Bitrex? Commercial Operations. As the world's most bitter substance, Bitrex is a trusted aversive agent that is widely used to prevent accidental ingestion of harmful substances and forms a crucial part of the Veranova portfolio. With this change, Cécile will be leading the strategy, business development, and operational direction for Bitrex to continue Veranova's mission of supporting global partners to develop safe and innovative products. Learn more about Cécile's appointment and how it will enable us to enhance the vital role of Bitrex in protecting consumer health: https://lnkd.in/gY8xU27P
-
In this week’s #PharmorphixFix post, Veranova’s Principal Team Lead, Susana del Río, and Team Leader, Claire Wombwell, explain how our Pharmorphix team identified the optimal solid form of a customer’s compound. Find out below how we designed a comprehensive screening approach to help the customer build on their existing knowledge of the compound's polymorphism and gain greater confidence in the order of stability of the different forms. Interested in learning more? Visit our website to read more about our solid form screening expertise and capabilities: https://veranova.com/
-
Did you know that 1 in 5 FDA-approved small molecule drugs since 2014 have collaborated with us? With our proven track record of delivering excellence in drug development and manufacturing, we have the capabilities and expertise to help you overcome API complexity with confidence. Visit our website to learn more and discover how we can work closely with you to optimize your project: https://veranova.com
-
In our latest #PharmorphixFix post, Veranova’s Senior Scientist, Ruth Lunt, explains how our Pharmorphix team helped a customer resolve batch-to-batch API manufacturing inconsistency through solid form and particle size control. Find out below how the team undertook a range of studies, employing multiple techniques and analyses, to develop a solution that resulted in high product yields and facilitated particle size optimization. You can also visit our website to find out more about our solid form and particle engineering capabilities and discover how we can help you overcome API complexity: https://lnkd.in/ehMqRZHK
-
Tomorrow, Veranova’s Solid Form Scientists, Shane Cullen, and Jethro Beamish-Cook, will be delivering a Scientific Update Ltd webinar entitled “From Vials to Vessels: Discovery and Development of a Salt/Cocrystal Switch - Demonstrating Process Control at Scale incorporating Particle Engineering Strategies”. In the webinar, Shane and Jethro will be exploring the role of crystallization control in obtaining solid form APIs with optimal physiochemical properties. They will also be presenting a case study that provides insight into each step of the development process, from initial form discovery and screening to scale-up and application of particle engineering techniques. Find out more about the webinar and sign up to watch live: https://lnkd.in/eHE4S3aw
-
Veranova would like to wish a Happy Veterans Day, Remembrance Day for our colleagues in the UK, to all those who have served or are currently serving. We were proud to sponsor the Journey Home 5k/10k Race yesterday at Rogers Field in Devens, Massachusetts to benefit Clear Path for Veterans New England and look forward to a special global panel later this morning to hear from the veterans, first responders, active military and their families, who work alongside us.
-
In this week's #MeetVeranova post, we are hearing from Ian Cooper, Quality Manager at our Cambridge, UK site. During his 19-year tenure with our Pharmorphix team, Ian has played a crucial role in helping us ensure successful project delivery and maintain our quality certifications, including ISO 9001. Learn more about Ian's role below and find out why he decided to return from early retirement to rejoin our team.?
-
The Veranova team is looking forward to being in Hamburg, Germany next week for Informa Connect’s #TIDESEurope event and learning about the latest trends and technologies in the oligonucleotide and peptide space. If you’re also attending, make sure to keep an eye out for Cécile Maupas, Rohtash Kumar, and Christophe Sanfilippo. You can also get in touch now to book a meeting with the team: https://lnkd.in/gqDcGEPT
-
The Veranova team are at World ADC Event Series, San Diego! We are excited to discuss ADC development and manufacturing to learn how we can help you navigate your path towards commercialization. Visit Booth 314 to learn more. Also, don't miss out on our Global VP, Chemical Development Operations, William Sanders, giving a talk at 11:30 am PT entitled "Implementing Practical Flash Chromatography for Clinical ADC Payload-Linker Production"!